Marcio Souza

Marcio Souza, listed as chief executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Praxis Precision Medicines, Inc. and Spyre Therapeutics, Inc. The record holds 21 filings, for trades running from 18 August 2021 to 8 July 2026.

No open-market sale appears; the market trades are 5 purchases worth €263k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 13 share grants.

The median purchase comes to €47k. Of 5 purchases, 2 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The record was last updated on 8 July 2026 with a transaction in Praxis Precision Medicines, Inc. The latest purchase dates back some time: it was published 1,209 days ago, on 27 June 2023. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.